In-depth Interrogation: Health Secretary Grilled for Eight Hours by CID in Substandard Medicine Import Probe

In the ongoing investigation into the importation of a batch of substandard human intravenous immunoglobulin (IVIG) from India into Sri Lanka, the Criminal Investigation Department (CID) has taken an extensive statement from Janaka Sri Chandra Gupta, the Secretary to the Health Ministry. The CID officers conducted the questioning session from 9:30 am to 5:30 pm, delving into critical aspects of the case.

The investigation has gained momentum, with the CID intensifying efforts to unravel the complexities surrounding the importation of the substandard medicine. Last week, the CID took a significant step by arresting the owner of the local supplier, Isolez Biotech Pharma AG (Pvt.) Ltd. The individual, whose identity is currently undisclosed, faced legal consequences, being remanded until November 15 after a court appearance.

The prolonged questioning of the Health Secretary underscores the gravity of the situation and the determination of the CID to scrutinize all angles of the case. As the investigation unfolds, the authorities aim to shed light on the circumstances leading to the importation of substandard medical supplies and hold those responsible accountable for any wrongdoing. The upcoming developments in this investigation will likely provide further insights into the extent of the issue and potential implications for public health and safety.

Unraveling the Medicine Import Saga

The extensive interrogation of Health Secretary Janaka Sri Chandra Gupta by the Criminal Investigation Department (CID) marks a pivotal development in the investigation surrounding the importation of substandard human intravenous immunoglobulin (IVIG) into Sri Lanka. The eight-hour session underscores the seriousness with which authorities are approaching the case, delving into crucial details to unearth the truth.

The arrest of the owner of the local supplier, Isolez Biotech Pharma AG (Pvt.) Ltd, adds a layer of legal consequences to the investigation. With the individual remanded until November 15, the legal proceedings are underway, reflecting the commitment to holding those involved accountable.

As the CID meticulously navigates the complexities of the case, the public awaits further revelations that may shed light on the circumstances leading to the importation of substandard medical supplies. The outcome of this investigation holds implications not only for the individuals directly involved but also for broader concerns surrounding public health and safety. The upcoming developments in this ongoing saga will be crucial in determining the extent of the issue and ensuring accountability for any wrongdoing.